Phase 3 Readout

KOD: Phase 3 Topline: A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Three-arm Phas

Name: Phase 3 Topline: A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Three-arm Phas
Start: 2027-08-01
End: 2027-08-01

August 1, 2027. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date: August 1, 2027
Company: Kodiak Sciences Inc. (KOD)

BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Phase 3 Readout~month

Phase 3 Topline: A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Three-arm Phas

August 1, 2027

KOD overview →

Company: Kodiak Sciences Inc. (KOD)
Indication: Wet Age-related Macular Degeneration